Crown Wealth Group LLC Acquires Shares of 8,486 GRAIL, Inc. (NASDAQ:GRAL)

Crown Wealth Group LLC acquired a new stake in shares of GRAIL, Inc. (NASDAQ:GRAL - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 8,486 shares of the company's stock, valued at approximately $217,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Lindbrook Capital LLC purchased a new position in GRAIL during the fourth quarter valued at $28,000. State of Tennessee Department of Treasury bought a new position in shares of GRAIL in the fourth quarter worth about $28,000. Caldwell Sutter Capital Inc. purchased a new position in shares of GRAIL during the 1st quarter valued at about $28,000. Sterling Capital Management LLC purchased a new position in shares of GRAIL during the 4th quarter valued at about $29,000. Finally, Wellington Shields Capital Management LLC bought a new position in shares of GRAIL during the 4th quarter valued at approximately $33,000.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. Canaccord Genuity Group increased their price objective on shares of GRAIL from $32.00 to $43.00 and gave the stock a "buy" rating in a research note on Wednesday, May 14th. Morgan Stanley upped their target price on shares of GRAIL from $16.00 to $20.00 and gave the stock an "equal weight" rating in a report on Tuesday, March 18th.

Insiders Place Their Bets

In other GRAIL news, CFO Aaron Freidin sold 41,150 shares of GRAIL stock in a transaction that occurred on Friday, May 2nd. The shares were sold at an average price of $33.93, for a total transaction of $1,396,219.50. Following the completion of the sale, the chief financial officer directly owned 294,020 shares in the company, valued at approximately $9,976,098.60. The trade was a 12.28% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, President Joshua J. Ofman sold 9,692 shares of the business's stock in a transaction dated Monday, June 30th. The shares were sold at an average price of $52.00, for a total value of $503,984.00. Following the completion of the transaction, the president directly owned 492,076 shares of the company's stock, valued at approximately $25,587,952. This trade represents a 1.93% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 193,090 shares of company stock valued at $6,726,678.

GRAIL Trading Down 3.4%

Shares of NASDAQ:GRAL traded down $1.67 during midday trading on Wednesday, reaching $47.56. 1,418,355 shares of the company were exchanged, compared to its average volume of 1,201,173. The stock has a market cap of $1.71 billion and a PE ratio of -0.78. The business's fifty day moving average is $40.14 and its two-hundred day moving average is $32.28. GRAIL, Inc. has a one year low of $12.33 and a one year high of $63.99.

GRAIL (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings data on Tuesday, May 13th. The company reported ($3.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.03) by $0.93. GRAIL had a negative net margin of 1,464.53% and a negative return on equity of 17.99%. The company had revenue of $31.84 million during the quarter, compared to analysts' expectations of $35.80 million. As a group, sell-side analysts expect that GRAIL, Inc. will post -15.15 EPS for the current year.

GRAIL Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.